Michael Pergine

Michael leads U.S. Commercial & Government Affairs, which includes responsibility for our women’s health, dermatology, biosimilars and general medicines portfolios in our U.S. market, as well as Federal, State and Trade Government Affairs and Public Policy. He leads a team focused on driving growth and achieving our most strategic objectives in this key market.

With an extensive 30-year career, predominantly in commercial roles, Michael most recently was Organon’s Chief Government Affairs & Policy Officer and a member of our Executive Leadership Team. In this role he directed global government engagement and strategic policy-shaping efforts across the full portfolio of franchises and markets.

Prior to joining Organon, Michael spent 25 years at Merck, known as MSD outside the U.S. and Canada, where he led global strategy and operations for the HPV vaccine franchise. In addition, he engaged in product development activities for multiple assets, managed global supply chains, led vaccine business development and alliance management activities, oversaw strategic planning efforts across an integrated R&D, manufacturing & supply and commercial vaccine enterprise, and represented the company to government officials around the world. Previously, he was a Senior Consultant at both Ernst & Young and BDM Technologies, where he engaged with multiple global companies across several continents, in various industry sectors.

Michael has a B.S. in logistics from Penn State University and additional executive education certifications from the Wharton School, Duke University Fuqua School of Business, Harvard Business School, and Georgetown University McCourt School of Public Policy. He is a Board Member of the US-ASEAN Business Council, and the National Center for APEC (Asia Pacific Economic Cooperative).